ADIM
EVBG

Alpha DNA Investment Management’s Everbridge, Inc. Common Stock EVBG Stock Holding History

Alpha DNA Investment Management’s Portfolio EVBG Stock Details EVBG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-37,367
Closed -$1.11M – 214
2022
Q4 		$1.11M Buy
+37,367
New +$1.15M 0.39% 74

Other funds holding EVBG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Alpha DNA Investment Management's EVBG Position: Q1 2023 in Review

Alpha DNA Investment Management sold out of Everbridge, Inc. Common Stock (EVBG) in Q1 2023, closing a stake of 37,367 shares — an estimated $1.11M sold.

Alpha DNA Investment Management first reported a position in EVBG in Q4 2022 and held it in 1 quarter. The position peaked at $1.11M in Q4 2022. 210 funds tracked by Wall St. Rank hold EVBG as of Q1 2023.

  • Alpha DNA Investment Management reported no remaining Everbridge, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 37,367 Everbridge, Inc. Common Stock shares in Q1 2023, an estimated $1.11M.
  • Alpha DNA Investment Management first reported a position in Everbridge, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's Everbridge, Inc. Common Stock position peaked at $1.11M in Q4 2022.
  • 210 funds tracked by Wall St. Rank held Everbridge, Inc. Common Stock as of Q1 2023.

Based on Alpha DNA Investment Management's 13F filing for Q1 2023, filed 5 May 2023.